Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 989 M998 M958 M948 M994 M990 M 3.89 B Research & development —————— — Operating income 287 M312 M274 M153 M217 M225 M 869 M Non-Operating Income, Total -51 M-52 M-51 M338 M-50 M-45 M 192 M Interest expense, net of interest capitalized -62 M-63 M-55 M-44 M-53 M-55 M -207 M Non-Operating Income, excl. Interest Expenses -62 M-63 M0438 M00 438 M Unusual income/expense 11 M11 M4 M-56 M3 M10 M -39 M Pretax income 237 M259 M223 M82 M213 M178 M 696 M Equity in earnings 1 M-1 M01 M46 M-2 M 45 M Taxes 66 M68 M45 M31 M44 M48 M 168 M Non-controlling/minority interest —————— — After tax other income/expense -2 M3 M24 M-57 M-18 M5 M -46 M Net income before discontinued operations 158 M193 M178 M75 M77 M134 M 464 M Discontinued operations 11 M7 M2 M-9 M2 M2 M -3 M Net income 169 M193 M180 M66 M79 M136 M 461 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 169 M193 M180 M66 M79 M136 M 461 M Basic earnings per share (Basic EPS) 0.650.750.70.260.310.53 1.8 Diluted earnings per share (Diluted EPS) 0.650.750.70.250.310.53 1.79 Average basic shares outstanding 259.1 M258.1 M257.1 M257.5 M255.4 M254.6 M — Diluted shares outstanding 259.6 M258.3 M257.3 M257.8 M255.9 M254.7 M — EBITDA 393 M422 M383 M398 M331 M328 M 1.44 B EBIT 293 M317 M276 M421 M232 M225 M 1.15 B Cost of revenue 2.09 B2.23 B2.16 B1.91 B2.14 B2.09 B 8.29 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 100 M105 M107 M106 M99 M103 M 415 M